John Militello Rocket Pharmaceuticals, Inc. (RCKT) insider trading activity

RCKT Quotes by TradingView

John Militello is of ROCKET PHARMACEUTICALS, INC.. Currently has a direct ownership of 49,310 shares of RCKT, which is worth approximately $575,940. The most recent transaction as insider was on Nov 21, 2024, when has been sold 1,224 shares (Common Stock) at a price of $13.05 per share, resulting in proceeds of $15,973. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 49.3K
4.16% 3M change
419.87% 12M change
Total Value Held $575,940

John Militello Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 21 2024
SELL
Open market or private sale
$15,973 $13.05 p/Share
1,224 Reduced 2.42%
49,310 Common Stock
Oct 31 2024
SELL
Open market or private sale
$15,240 $16.62 p/Share
917 Reduced 1.78%
50,534 Common Stock
Aug 16 2024
SELL
Open market or private sale
$19,684 $18.5 p/Share
1,064 Reduced 2.03%
51,451 Common Stock
Jul 22 2024
SELL
Open market or private sale
$18,692 $23.02 p/Share
812 Reduced 1.52%
52,515 Common Stock
May 16 2024
SELL
Open market or private sale
$25,194 $23.35 p/Share
1,079 Reduced 1.98%
53,327 Common Stock
Apr 22 2024
SELL
Open market or private sale
$19,050 $22.87 p/Share
833 Reduced 1.51%
54,406 Common Stock
Mar 21 2024
SELL
Open market or private sale
$69,969 $28.1 p/Share
2,490 Reduced 4.31%
55,239 Common Stock
Feb 29 2024
SELL
Open market or private sale
$298,400 $29.84 p/Share
10,000 Reduced 31.73%
21,517 Common Stock
Feb 29 2024
BUY
Exercise of conversion of derivative security
$125,500 $12.55 p/Share
10,000 Added 24.09%
31,517 Common Stock
Feb 16 2024
SELL
Open market or private sale
$96,621 $29.84 p/Share
3,238 Reduced 19.7%
13,195 Common Stock
Feb 16 2024
BUY
Grant, award, or other acquisition
-
8,322 Added 27.89%
21,517 Common Stock
Feb 14 2024
BUY
Exercise of conversion of derivative security
-
6,274 Added 27.63%
16,433 Common Stock
Jan 22 2024
SELL
Open market or private sale
$17,353 $27.2 p/Share
638 Reduced 5.91%
10,159 Common Stock
Jan 18 2024
BUY
Exercise of conversion of derivative security
-
1,586 Added 12.81%
10,797 Common Stock
Nov 14 2023
BUY
Exercise of conversion of derivative security
-
725 Added 7.1%
9,485 Common Stock
Oct 20 2023
SELL
Open market or private sale
$9,621 $17.06 p/Share
564 Reduced 6.05%
8,760 Common Stock
Aug 17 2023
SELL
Open market or private sale
$4,393 $15.47 p/Share
284 Reduced 4.85%
5,570 Common Stock
Aug 14 2023
BUY
Exercise of conversion of derivative security
-
725 Added 8.45%
7,854 Common Stock
Jul 20 2023
SELL
Open market or private sale
$10,904 $19.03 p/Share
573 Reduced 7.44%
7,129 Common Stock
Jul 18 2023
BUY
Exercise of conversion of derivative security
-
1,586 Added 17.08%
7,702 Common Stock
May 17 2023
SELL
Open market or private sale
$5,238 $21.38 p/Share
245 Reduced 3.85%
6,116 Common Stock
May 14 2023
BUY
Exercise of conversion of derivative security
-
725 Added 10.23%
6,361 Common Stock
Apr 21 2023
SELL
Open market or private sale
$43,678 $18.65 p/Share
2,342 Reduced 29.36%
5,636 Common Stock
Apr 18 2023
BUY
Exercise of conversion of derivative security
-
6,364 Added 44.37%
7,978 Common Stock
Feb 17 2023
SELL
Open market or private sale
$23,710 $19.06 p/Share
1,244 Reduced 43.53%
1,614 Common Stock
JM

John Militello

Cranbury, NJ

Track Institutional and Insider Activities on RCKT

Follow ROCKET PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCKT shares.

Notify only if

Insider Trading

Get notified when an Rocket Pharmaceuticals, Inc. insider buys or sells RCKT shares.

Notify only if

News

Receive news related to ROCKET PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RCKT